Correlation Between Cullinan Oncology and Ayala Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Cullinan Oncology and Ayala Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cullinan Oncology and Ayala Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Cullinan Oncology LLC and Ayala Pharmaceuticals, you can compare the effects of market volatilities on Cullinan Oncology and Ayala Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cullinan Oncology with a short position of Ayala Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cullinan Oncology and Ayala Pharmaceuticals.

Diversification Opportunities for Cullinan Oncology and Ayala Pharmaceuticals

0.0

Correlation Coefficient

Cullinan Oncology  Ayala Pharmaceuticals

Pay attention - limited upside

The 3 months correlation between Cullinan and Ayala is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Cullinan Oncology LLC and Ayala Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Ayala Pharmaceuticals and Cullinan Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cullinan Oncology LLC are associated (or correlated) with Ayala Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Ayala Pharmaceuticals has no effect on the direction of Cullinan Oncology i.e., Cullinan Oncology and Ayala Pharmaceuticals go up and down completely randomly.

Pair Corralation between Cullinan Oncology and Ayala Pharmaceuticals

If you would invest (100.00) in Ayala Pharmaceuticals on December 29, 2024 and sell it today you would earn a total of  100.00  from holding Ayala Pharmaceuticals or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Cullinan Oncology LLC  vs.  Ayala Pharmaceuticals

Cullinan Oncology LLC

Risk-Adjusted Performance

Very Weak

Over the last 90 days Cullinan Oncology LLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of uncertain performance in the last few months, the Stock's technical and fundamental indicators remain very healthy which may send shares a bit higher in April 2025. The recent disarray may also be a sign of long period up-swing for the firm investors.

Ayala Pharmaceuticals

Risk-Adjusted Performance

Very Weak

Over the last 90 days Ayala Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Ayala Pharmaceuticals is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Pair Trading with Cullinan Oncology and Ayala Pharmaceuticals

The main advantage of trading using opposite Cullinan Oncology and Ayala Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cullinan Oncology position performs unexpectedly, Ayala Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Ayala Pharmaceuticals will offset losses from the drop in Ayala Pharmaceuticals' long position.

The idea behind Cullinan Oncology LLC and Ayala Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Analysis module to research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities.